Approval · Notice of Compliance 33167 · 2024
MULTI-12 INJECTION: Notice of Compliance 33167
Issued May 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33167
- Date
- May 3, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MULTI-12 INJECTION | Not yet assigned | — |
Medicinal ingredients
- BIOTIN 12 MCG per ML
- ASCORBIC ACID 20 MG per ML
- DEXPANTHENOL 3 MG per ML
- FOLIC ACID 80 MCG per ML
- PYRIDOXINE HYDROCHLORIDE 0.8 MG per ML
- RIBOFLAVIN-5-PHOSPHATE 0.72 MG per ML
- THIAMINE HCL 0.6 MG per ML
- VITAMIN A 660 UNIT per ML
- VITAMIN B12 1 MCG per ML
- VITAMIN D 40 UNIT per ML
- VITAMIN E 2 UNIT per ML
- NICOTINAMIDE 8 MG per ML